Back
Aptevo Therapeutics Stock Price Chart
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.
Sell
27
APVO
Aptevo Therapeutics
Last Price:
$4.36
Seasonality Move:
-31.63%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APVO is experiencing slight selling pressure.
Aptevo Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.12 | Sell |
| 20-day SMA: | 8.24 | Sell |
| 50-day SMA: | 8.71 | Sell |
| 200-day SMA: | 32.53 | Sell |
| 8-day EMA: | 5.29 | Sell |
| 20-day EMA: | 7.09 | Sell |
| 50-day EMA: | 8.69 | Sell |
| 200-day EMA: | 168.98 | Sell |
Aptevo Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.47 | Sell |
| Relative Strength Index (14 RSI): | 35.08 | Sell |
| Chaikin Money Flow: | -43529 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.66 - 11.16) | Sell |
| Bollinger Bands (100): | (6.54 - 13.42) | Sell |
Aptevo Therapeutics Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Aptevo Therapeutics Stock
Is Aptevo Therapeutics Stock a Buy?
-
Aptevo Therapeutics share price is 4.36 while APVO 8-day simple moving average is 5.12, which is a Sell signal.
-
The stock price of APVO is 4.36 while Aptevo Therapeutics 20-day SMA is 8.24, which makes it a Sell.
-
Aptevo Therapeutics 50-day simple moving average is 8.71 while APVO share price is 4.36, making it a Sell technically.
-
APVO stock price is 4.36 and Aptevo Therapeutics 200-day simple moving average is 32.53, creating a Sell signal.
APVO Technical Analysis vs Fundamental Analysis
Sell
27
Aptevo Therapeutics (APVO)
is a Sell
Is Aptevo Therapeutics a Buy or a Sell?
-
Aptevo Therapeutics stock is rated a SellThe current Aptevo Therapeutics [APVO] share price is $4.36. The Score for APVO is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
Aptevo Therapeutics Stock Info
Market Cap:
2.2M
Price in USD:
4.36
Share Volume:
93K
Aptevo Therapeutics 52-Week Range
52-Week High:
399.60
52-Week Low:
3.65
Sell
27
Aptevo Therapeutics (APVO)
is a Sell
Aptevo Therapeutics Share Price Forecast
-
What is the Aptevo Therapeutics stock price today?The Aptevo Therapeutics stock price is 4.36 USD today.
-
Will APVO stock go up or go down?Aptevo Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Aptevo Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aptevo Therapeutics is overvalued.
Is Aptevo Therapeutics Stock a Buy?
-
Aptevo Therapeutics share price is 4.36 while APVO 8-day exponential moving average is 5.29, which is a Sell signal.
-
The stock price of APVO is 4.36 while Aptevo Therapeutics 20-day EMA is 7.09, which makes it a Sell.
-
Aptevo Therapeutics 50-day exponential moving average is 8.69 while APVO share price is 4.36, making it a Sell technically.
-
APVO stock price is 4.36 and Aptevo Therapeutics 200-day simple moving average is 168.98, creating a Sell signal.
Fundamental Analysis of Aptevo Therapeutics
Is Aptevo Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $17.55 per share, a decrease next quarter of $0.00 per share, an increase this year of $3,536.34 per share, and an increase next year of $71.15 per share.
Technical Analysis of Aptevo Therapeutics
Should I short Aptevo Therapeutics stock?
-
APVO Moving Average Covergence Divergence (MACD) indicator is -1.47, suggesting Aptevo Therapeutics is a Sell
-
Aptevo Therapeutics Relative Strength Index (RSI) is 35.08, which suggest Aptevo Therapeutics is oversold
-
The Bollinger Bands (25) for Aptevo Therapeutics is (5.66 - 11.16), which suggest Aptevo Therapeutics is a Sell
-
The Bollinger Bands (100) for Aptevo Therapeutics is (6.54 - 13.42), which suggest Aptevo Therapeutics is a Sell
* Aptevo Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.